European Union regulators are weighing relaxing a prohibition on direct communication with patients by drug companies.
European Medicines Agency head Peter Arlett told Bloomberg the European Commission “will revise the proposals to clarify and harmonize the rules in what companies can and can’t say to patients.”
There has long been talk of liberalization of consumer promotion regs in Europe, though US-style ads are not in the cards. However, regulators have in the past indicated openness to letting drug makers put more information online and communicate with patients through opt-in direct mail and emails.
From the September 01, 2011 Issue of MM+M - Medical Marketing and Media
